Dana Investment Advisors, Inc. Astrazeneca PLC Transaction History

Dana Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $175,109 - $211,855	2,621 New	2,621 $204,000
Q4 2023 Feb 07, 2024	SELL	$61.89 - $69.28 $342,499 - $383,395	-5,534 Reduced 50.74%	5,373 $361,000
Q3 2023 Nov 15, 2023	BUY	$64.85 - $71.7 $215,691 - $238,474	3,326 Added 43.87%	10,907 $738,000
Q2 2023 Aug 15, 2023	BUY	$69.91 - $75.81 $529,987 - $574,715	7,581 New	7,581 $542,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.